TABLE 3.
Comparison of anticandidal activities for whole saliva from HIV-positive patients and healthy controlsa
| Subject group (n) | Salivary flow rate (ml/min) | % Inhibition
|
|
|---|---|---|---|
| Blastoconidial viability | Germ tube formation | ||
| HIV positive (12) | 1.21 (0.64–1.35)b | 88.8 (70.4–95.2)c | 80.3 (11.1–87.7)b |
| Control (17) | 2.00 (1.48–2.40) | 100 (97.9–100) | 100 (100–100) |
Each value is the median with the 25th and 75th percentiles indicated in parentheses.
Significantly different from the control (P < 0.001).
Significantly different from the control (P < 0.05).